New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 26, 2013
07:48 EDTAVNRAvanir Pharmaceuticals receives CHMP opinion for approval of Nuedexta in Europe
Avanir Pharmaceuticals announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for Nuedexta, recommending Nuedexta be approved for the treatment of pseudobulbar affect, irrespective of neurologic cause. In addition, the CHMP also recommended approval of two dose strengths of Nuedexta; 20/10 mg and 30/10 mg capsules.
News For AVNR From The Last 14 Days
Check below for free stories on AVNR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
09:18 EDTAVNRFDA accepts Avanir's IND application for Phase II study for AVP-786
Subscribe for More Information
July 16, 2014
09:13 EDTAVNRAvanir's Nuedexta shows positive early results in clinical study of Alzheimer's
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use